Suraksha Diagnostic's audit record is clean across every year reviewed, with unqualified opinions and no reported fraud, wilful default, or disputed statutory dues. The record also shows operating cash flow consistently exceeding reported profit. The issues that deserve attention sit around the group's structure, a new goodwill-bearing acquisition, subsidiaries audited by other firms, and one unaudited entity, and a recurring software compliance lapse that leaves prior-period records unverifiable.
Key findings
- Audit opinions are clean, but the audit-trail feature was enabled late, leaving prior-period records unverifiable
Major- The standalone and consolidated auditor's reports for FY2025-26 were unqualified, signed by M S K A & Associates LLP on 21 May 2026, with Key Audit Matters reported. The audit trail feature in the Microsoft AX Dynamics ERP was enabled only from 24 October 2025 at application level and 27 October 2025 at database level, so the auditor could not comment whether prior-year records were preserved per Rule 11(g). In one subsidiary, the feature was not enabled throughout FY2025-26. - Borrowings are modest and secured, but deferred-payment capex and undrawn sanctioned loans sit beyond the debt line
Minor- The Group had no supplier finance arrangements during FY2026. A financing component of ₹78.01 lakhs was recognised as finance cost on Capex Supply Arrangements with deferred payment terms. Additional term loans of 19.64 crore were sanctioned but yet to be utilized as of 31 March 2026. Crisil Ratings upgraded the long-term rating from 'Crisil B (Issuer Not Cooperating) / Stable' to 'Crisil A- / Stable' on 08 October 2025. - Promoter conduct is routine: no pledge build-up, no promoter ESOP participation, and two notable resignations
Minor- Promoter shareholding stood at 49.10% with pledge at 0.10% versus 0.00% one year prior. ESOP 2024 ratification passed on 10 February 2025 with 81.23% votes in favour, but public institutional shareholders voted 75.80% against. Mr. Arun Sadhanandham, the OrbiMed nominee director, resigned effective 06 June 2025, and Group CFO Mr. K S Ravindra tendered resignation on 02 March 2026, ceasing office from 31 May 2026. - Operating cash flow consistently exceeds profit, and capital allocation is conservative
Clean- Consolidated CFO was ₹81.83 crore in FY26 against PAT of ₹31.40 crore, exceeding PAT in each of the last four years. ROCE improved from 15.00% in FY24 to 23.16% in FY26. No CWIP or intangible asset project had completion overdue, cost exceeding original plan, or was temporarily suspended as at 31 March 2026.
What to watch
- Undrawn sanctioned term loans. 19.64 crore of sanctioned term loans remained unutilized as of 31 March 2026.
- Group CFO vacancy. The position following K S Ravindra's resignation effective 31 May 2026 is to be filled within prescribed timelines.
Bottom line: This is a clean audit record with strong cash conversion and improving returns. The risk character is one of group-structure opacity, a new goodwill-bearing acquisition, subsidiaries audited by other firms, and one unaudited entity, plus a software compliance lapse that leaves prior-period records unverifiable. Watch whether the undrawn sanctioned loans get deployed and how the CFO vacancy is filled.